Risk of leptomeningeal carcinomatosis in patients with brain metastases treated with stereotactic radiosurgery

Journal of Neuro-Oncology

Volumn 136, Issue 2, 2018, Pages 395-401

  Ma, Rosaline ^a   Levy, Morgan ^a   Gui, Bin ^a   Lu, Shou En ^b   Narra, Venkat ^c   Goyal, Sharad ^a   Danish, Shabbar ^a   Hanft, Simon ^a   Khan, Atif J ^a   Malhotra, Jyoti ^a   Motwani, Sabin ^a   Jabbour, Salma K ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS SCHOOL OF PUBLIC HEALTH   (United States)

^c Summit Medical Group   (United States)

Author keywords

Brain metasteses; Leptomeningeal carcinomatosis; Risk factor; Stereotactic radiosurgery

Indexed keywords

ADULT; ARTICLE; BRAIN DAMAGE; BRAIN METASTASIS; BRAIN SURGERY; BREAST CANCER; CARCINOMATOUS MENINGITIS; CASE CONTROL STUDY; CONTROLLED STUDY; DECISION MAKING; DEMOGRAPHY; DISEASE COURSE; FEMALE; GAMMA KNIFE RADIOSURGERY; HISTOLOGY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MELANOMA; METASTASIS RESECTION; MIDDLE AGED; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; RETROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; SURVIVAL ANALYSIS; TUMOR LOCALIZATION; UNIVARIATE ANALYSIS; WHOLE BRAIN RADIOTHERAPY; BRAIN TUMOR; CRANIOTOMY; RADIOSURGERY; SECONDARY; TREATMENT OUTCOME;

BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CRANIOTOMY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MENINGEAL CARCINOMATOSIS; MIDDLE AGED; RADIOSURGERY; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 85034600425     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-017-2666-7     Document Type: Article

References (31)

1. Nayak L, Lee EQ, Wen PY (2012) Epidemiology of brain metastases. Curr Oncol Rep 14(1):48–54
2. Delattre JY, Krol G, Thaler HT, Posner JB (1998) Distribution of brain metastases. Arch Neurol 45:741–744
3. Van Horn A, Chamberlain MC (2012) Neoplastic meningitis. J Support Oncol 10(2):45–53
4. Chamberlain MC, Corey-Bloom J (1991) Leptomeningeal metastases: 111-indium-DTPA CSF flow studies. Neurology 41:1765–1769
5. Grossman SA, Krabak MJ (1999) Leptomeningeal carcinomatosis. Cancer Treat Rev 25(2):103–119
6. Chamberlain MC, Sandy AD, Press GA (1990) Leptomeningeal metastasis: a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain. Neurology 40:435–438
7. Aoyama H, Shirato H, Tago M et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295(21):2483–2491
8. Chang EL, Wefel JS, Hess KR et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10(11):1037–1044
9. Lippitz B, Lindquist C, Paddick I, Peterson D, O’Neill K, Beaney R (2014) Stereotactic radiosurgery in the treatment of brain metastases: the current evidence. Cancer Treat Rev 40(1):48–59
10. Hartford AC, Paravati AJ, Spire WJ et al (2013) Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size. Int J Radiat Oncol Biol Phys 3(85):650–655
11. Ring KS, Ge B, Petroski G et al (2016) Radiosurgery to the postoperative tumor bed for metastatic carcinoma versus whole brain radiation after surgery. Cureus 8(11):e885
12. Sahgal A, Aoyama H, Kocher M et al (2015) Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis. Int J Radiat Oncol Biol Phys 91(4):710–717
13. Gaspar L, Scott C, Rotman M et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37(4):745–751
14. Chamberlain MC (2010) Leptomeningeal metastasis. Curr Opin Oncol 22(6):627–635
15. Jung JM, Kim S, Joo J, Shin KH, Gwak HS, Lee SH (2012) Incidence and risk factors for leptomeningeal carcinomatosis in breast cancer patients with parenchymal brain metastases. J Korean Neurosurg Soc 52(3):193–199
16. Ojerholm E, Lee JY, Kolker J, Lustig R, Dorsey JF, Alonso-Basanta M (2014) Gamma Knife radiosurgery to four or more brain metastases in patients without prior intracranial radiation or surgery. Cancer Med 3(3):565–571
17. Ojerholm E, Lee JY, Thawani JP et al (2014) Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis. J Neurosurg 121(Suppl):75–83
18. Gans JH, Raper DM, Shah AH et al (2013) The role of radiosurgery to the tumor bed after resection of brain metastases. Neurosurgery 72(3):317–325
19. Iorio-morin C, Masson-côté L, Ezahr Y, Blanchard J, Ebacher A, Mathieu D (2014) Early gamma knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control. J Neurosurg 121(Suppl):69–74
20. van der ree TC, Dippel DW, Avezaat CJ, Sillevis smitt PA, Vecht CJ, van den Bent MJ (1999) Leptomeningeal metastasis after surgical resection of brain metastases. J Neurol Neurosurg Psychiatr 66(2):225–227
21. Mahajan A, Borden J, Tsai JS (2002) Carcinomatous meningitis: are surgery or gamma knife radiosurgery treatment risk factors? J Neurosurg 97(5 Suppl):441–444
22. Suki D, Hatiboglu MA, Patel AJ et al (2009) Comparative risk of leptomeningeal dissemination of cancer after surgery or stereotactic radiosurgery for a single supratentorial solid tumor metastasis. Neurosurgery 64(4):664–674
23. Atalar B, Modlin LA, Choi CY et al (2013) Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys 87(4):713–718
24. Johnson MD, Avkshtol V, Baschnagel AM et al (2016) Surgical resection of brain metastases and the risk of leptomeningeal recurrence in patients treated with stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 94(3):537–543
25. Fortner JG (1993) Inadvertent spread of cancer at surgery. J Surg Oncol 53(3):191–196
26. Ahn JH, Lee SH, Kim S et al (2012) Risk for leptomeningeal seeding after resection for brain metastases: implication of tumor location with mode of resection. J Neurosurg 116(5):984–993
27. Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD (2006) Stereotactic radiosurgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys 64(3):898–903
28. Wilhelm I, Molnár J, Fazakas C, Haskó J, Krizbai IA (2013) Role of the blood–brain barrier in the formation of brain metastases. Int J Mol Sci 14(1):1383–1411
29. Tsao MN, Lloyd N, Wong RK et al (2012) Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. Cochrane Database Syst Rev 4:CD003869
30. Bokstein F, Lossos A, Siegal T (1998) Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy. Cancer 82(9):1756–1763
31. Chamberlain MC, Kormanik PA, Barba D (1997) Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases. J Neurosurg 87(5):694–699